Abstract
EXPERIMENTAL autoimmune encephalomyelitis (EAE) is an inflammatory condition of the central nervous system with similarities to multiple sclerosis1,2. In both diseases, circulating leukocytes penetrate the blood-brain barrier and damage myelin, resulting in impaired nerve conduction and paralysis3–5. We sought to identify the adhesion receptors that mediate the attachment of circulating leukocytes to inflamed brain endothelium in EAE, because this interaction is the first step in leukocyte entry into the central nervous system. Using an in vitro adhesion assay on tissue sections, we found that lymphocytes and monocytes bound selectively to inflamed EAE brain vessels. Binding was inhibited by antibodies against the integrin molecule α4βl, but not by antibodies against numerous other adhesion receptors. When tested in vivo, anti-α4 integrin effectively prevented the accumulation of leukocytes in the central nervous system and the development of EAE. Thus, therapies designed to interfere with α4βl integrin may be useful in treating inflammatory diseases of the central nervous system, such as multiple sclerosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Paterson, P. Y. in Textbook of Immunopathology (eds Miescher, P. A. & Mueller-Eberhard, H. J.) 179–213 (Grune & Stratton, New York, 1976).
Alvord, E. C. Jr (ed.) Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis 1–511 (Liss, New York, 1984).
Wisniewski, H. M. & Keith, A. B. Ann. Neurol. 1, 144–148 (1977).
Traugott, U., McFarlin, D. E. & Raine, C. S. Cell Immun. 99, 395–410 (1986).
Zamvil, S. S. & Steinman, L. A. Rev. Immun. 8, 579–621 (1990).
Ben-Nun, A., Wekerle, H. & Cohen, I. R. Eur. J. Immun. 11, 195–199 (1981).
Hickey, W. F., Hsu, B. L. & Kimura, H. J. Neurosci. Res. 28, 254–260 (1991).
Stamper, H. B. & Woodruff, J. J. J. exp. Med 144, 828–833 (1976).
Hynes, R. O. Cell 48, 549–554 (1987).
Hemler, M. E. A. Rev. Immun. 8, 365–400.
Elices, M. J. et al. Cell 60, 577–584 (1990).
Schwartz, B. R., Wayner, E. A., Carlos, T. M., Ochs, H. D. & Harlan, J. M. J. clin. Invest. 85, 2019–2022 (1990).
Rice, G. E., Munro, J. M. & Bevilacqua, M. P. J. exp. Med. 171, 1369–1374 (1990).
Pulido, R. et al. J. biol. chem. 266, 10241–10245 (1991).
Briscoe, D. M. et al. Transplantation 51, 537–539 (1991).
Koch, A. E. et al. Lab. Invest. 64, 313–320 (1991).
Gallatin, W. M., Weissman, I. L. & Butcher, E. C. Nature 304, 30–34 (1983).
Jalkanen, S., Bargatze, R. F., de los Toyos, J. & Butcher, E. C. J. Cell Biol. 105, 983–990 (1987).
Picker, L. J., Nakache, M. & Butcher, E. C. J. Cell Biol. 109, 927–937 (1989).
Chin, Y.-H., Cai, J.-P. & Johnson, K. J. Immun. 145, 3669–3677 (1990).
Lawrence, M. B. & Springer, T. A. Cell 65, 859–874 (1991).
Luscinskas, F. W. et al. J. Immun. 146, 1617–1625 (1991).
Diamond, M. S., Staunton, D. E., Marlin, S. D. & Springer, T. A. Cell 65, 961–972 (1991).
Raine, C. S., Cannella, B., Duijvestijn, A. M. & Cross, A. H. Lab. Invest. 63, 476–490 (1990).
Wilcox, C. E. et al. J. Neuroimmun. 30, 43–51 (1990).
Cannella, B., Cross, A. H. & Raine, C. S. J. exp. Med. 172, 1521–1524 (1990).
Ferguson, T. A., Mizutani, H. & Kupper, T. S. Proc. natn. Acad. Sci. U.S.A. 88, 8072–8076 (1991).
Damle, N. K. & Aruffo, A. Proc natn. Acad. Sci. U.S.A. 88, 6403–6407 (1991).
Nojima, Y. et al. J. exp. Med. 172, 1185–1192 (1990).
Yednock, T. A., Butcher, E. C., Stoolman, L. M. & Rosen, S. D. J. Cell Biol. 104, 725–731 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yednock, T., Cannon, C., Fritz, L. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin. Nature 356, 63–66 (1992). https://doi.org/10.1038/356063a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/356063a0
This article is cited by
-
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Cancer Immunology, Immunotherapy (2024)
-
Gateway reflexes describe novel neuro-immune communications that establish immune cell gateways at specific vessels
Bioelectronic Medicine (2023)
-
The neuroimmune axis of Alzheimer’s disease
Genome Medicine (2023)
-
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro
Journal of Neuroinflammation (2023)
-
The novel HS-mimetic, Tet-29, regulates immune cell trafficking across barriers of the CNS during inflammation
Journal of Neuroinflammation (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.